Term: evaluable disease Pronunciation: (ee-VAL-yoo-uh-bul dih-ZEEZ) May 24, 2024October 7, 2025 Description: Disease that cannot be measured directly by the size of the tumor but can be evaluated by other methods specific to a particular clinical trial. Related Posts:FDA Approves ENDARI® for Sickle Cell DiseaseFDA Approves ENJAYMO® for Cold Agglutinin DiseaseOncoprescribe Blog Malignant Melanoma – An Elusive Disease?FDA Approves ENDARI®, A New Treatment for Sickle…FDA Approves DOPTELET® for Thrombocytopenia in…FDA Approves ADAKVEO®, A New Targeted Therapy for…